Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Taich Adam (CIK 1971187) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-11). Recent activity: Sell TXG (1,206 shares), Sell TXG (31,428 shares), Sell TXG (13,754 shares), Sell TXG (17,166 shares), Sell TXG (15,098 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-11 | 10x Genomics, Inc. (TXG) | Chief Financial Officer | Sell | 1,206 | $76,795 |
| 2026-09-11 | 10x Genomics, Inc. (TXG) | Chief Financial Officer | Sell | 31,428 | $2.0M |
| 2026-09-11 | 10x Genomics, Inc. (TXG) | Chief Financial Officer | Sell | 13,754 | $897,550 |
| 2026-08-26 | 10x Genomics, Inc. (TXG) | Chief Financial Officer | Sell | 17,166 | $1.1M |
| 2026-05-27 | 10x Genomics, Inc. (TXG) | Chief Financial Officer | Sell | 15,098 | $368,995 |
| 2026-03-02 | 10x Genomics, Inc. (TXG) | Chief Financial Officer | Buy | 106,579 | $0 |
| 2026-02-25 | 10x Genomics, Inc. (TXG) | Chief Financial Officer | Sell | 8,968 | $166,625 |
| 2025-11-25 | 10x Genomics, Inc. (TXG) | Chief Financial Officer | Sell | 11,888 | $225,872 |
| 2025-08-26 | 10x Genomics, Inc. (TXG) | Chief Financial Officer | Sell | 22,315 | $307,724 |
| 2025-05-27 | 10x Genomics, Inc. (TXG) | Chief Financial Officer | Sell | 4,044 | $33,565 |
Source: SEC Form 4 filings · as of 2026-09-11